Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Bromfenac Ophthalmic Solution Articles

ISTA Pharma accepts $500 million bid from Bausch & Lomb; settles royalty dispute

27 March 2012

Mylan debuts first generic of Xibrom ophthalmic solution and Risperidal, as well as Amrix which Watson also debuts

17 May 2011

ISTA Pharma accepts subpoena on Xibrom promotion

14 April 2008

Once-daily Xibrom effective in Ph III study

19 February 2007

ISTA to debut Xibrom in 2nd-qtr 2005

4 April 2005

ISTA's NDA for Xibrom to be reviewed by FDA

2 August 2004

ISTA's Xibrom on track for US approval

31 May 2004

Positive Ph III data for ISTA's Xibrom

15 March 2004

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Is the diabetes market facing a blockbuster-free future?
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Is the diabetes market facing a blockbuster-free future?
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS